Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Nasal application of HSV encoding human preproenkephalin blocks craniofacial pain in a rat model of traumatic brain injury

Gene Therapy volume 24, pages 482–486 (2017)Cite this article

Subjects

Abstract

According to Centers for Disease Control and Prevention, each year, an estimated 1.7 million Americans sustain a traumatic brain injury (TBI), which frequently leads to chronic craniofacial pain. In this study we examine a gene therapy approach to the treatment of post-TBI craniofacial neuropathic pain using nasal application of a herpes simplex virus (HSV)-based vector expressing human proenkephalin (SHPE) to target the trigeminal ganglia. Mild TBI was induced in rats by the use of a modified fluid percussion model. Two days after mild TBI, following the development of facial mechanical allodynia, animals received either an intranasal application of vehicle or recombinant HSV encoding human preproenkephalin or lacZ reporter gene encoding control vector (SHZ.1). Compared with baseline response thresholds, mild TBI in SHZ.1 or vehicle-treated animals induced a robust craniofacial allodynia lasting at least 45 days. On the other hand, nasal SHPE application 2 days post-TBI attenuated facial allodynia, reaching significance by day 4–7 and maintaining this effect throughout the duration of the experiment. Immunohistochemical examination revealed strong expression of human proenkephalin in trigeminal ganglia of SHPE, but not SHZ.1-treated rats. This study demonstrates that intranasal administration of HSV-based gene vectors may be a viable, non-invasive means of treating chronic craniofacial pain, including post-TBI pain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Coronado VG et al. Surveillance for traumatic brain injury-related deaths—United States, 1997–2007. MMWR Surveill Summ 2011; 60: 1–32.

    PubMed  Google Scholar 

  2. Erickson JC, Neely ET, Theeler BJ . Posttraumatic HEADACHE. Continuum (Minneap Minn) 2010; 16: 55–78.

    Google Scholar 

  3. Nampiaparampil DE . Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA 2008; 300: 711–719.

    Article  CAS  Google Scholar 

  4. Ofek H, Defrin R . The characteristics of chronic central pain after traumatic brain injury. Pain 2007; 131: 330–340.

    Article  Google Scholar 

  5. Theeler BJ, Erickson JC . Post-traumatic headaches: time for a revised classification? Cephalalgia 2012; 32: 589–591.

    Article  Google Scholar 

  6. Yeomans DC, Lu Y, Laurito CE, Peters MC, Vota-Vellis G, Wilson SP et al. Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia. Mol Ther 2006; 13: 589–597.

    Article  CAS  Google Scholar 

  7. Yeomans DC, Wilson SP . Herpes virus-based recombinant herpes vectors: gene therapy for pain and molecular tool for pain science. Gene Ther 2009; 16: 502–508.

    Article  CAS  Google Scholar 

  8. Tzabazis AZ, Klukinov M, Feliciano D, Wilson SP, Yeomans DC . Gene therapy for trigeminal pain in mice. Gene Ther 2014; 21: 1–5.

    Article  Google Scholar 

  9. Wilson SP, Yeomans DC, Bender Ma, Lu Y, Goins WF, Glorioso JC . Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96: 3211–3216.

    Article  CAS  Google Scholar 

  10. Goss JR, Harley CF, Mata M, O’Malley ME, Goins WF, Hu X et al. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol 2002; 52: 662–665.

    Article  CAS  Google Scholar 

  11. Lu Y, McNearney Ta, Lin W, Wilson SP, Yeomans DC, Westlund KN . Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae. Mol Ther 2007; 15: 1812–1819.

    Article  CAS  Google Scholar 

  12. Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 2001; 21: 7881–7888.

    Article  CAS  Google Scholar 

  13. Guedon J-MG, Wu S, Zheng X, Churchill CC, Glorioso JC, Liu C-H et al. Current gene therapy using viral vectors for chronic pain. Mol Pain 2015; 11: 1–23.

    Article  CAS  Google Scholar 

  14. Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D et al. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol 2011; 70: 207–212.

    Article  CAS  Google Scholar 

  15. Wolfe D, Mata M, Fink DJ . Targeted drug delivery to the peripheral nervous system using gene therapy. Neurosci Lett 2012; 527: 85–89.

    Article  CAS  Google Scholar 

  16. Wang Q, Guo J, Jia W . Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. Gene Ther 1997; 4: 1300–1304.

    Article  CAS  Google Scholar 

  17. Jiang Y, Wei N, Zhu J, Zhai D, Wu L, Chen M et al. A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain. Neuroscience 2012; 201: 96–104.

    Article  CAS  Google Scholar 

  18. Veening JG, Olivier B . Intranasal administration of oxytocin: behavioral and clinical effects, a review. Neurosci Biobehav Rev 2013; 37: 1445–1465.

    Article  CAS  Google Scholar 

  19. Lochhead JJ, Thorne RG . Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 2012; 64: 614–628.

    Article  CAS  Google Scholar 

  20. Alder J, Fujioka W, Lifshitz J, Crockett DP, Thakker-Varia S . Lateral fluid percussion: model of traumatic brain injury in mice. J Vis Exp 2011; pii: 3063.

    Google Scholar 

  21. Feliciano DP, Sahbaie P, Shi X, Klukinov M, Clark JD, Yeomans DC . Nociceptive sensitization and BDNF up-regulation in a rat model of traumatic brain injury. Neurosci Lett 2014; 583: 55–59.

    Article  CAS  Google Scholar 

  22. Ling GSF, Lee EY, Kalehua AN . Traumatic brain injury in the rat using the fluid-percussion model. Curr Protoc Neurosci 2004; Chapter 9: Unit 9.2.

  23. Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M et al. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther 2004; 11: 1648–1658.

    Article  CAS  Google Scholar 

  24. Todo T . Oncolytic virus therapy using genetically engineered herpes simplex viruses. Front Biosci 2008; 13: 2060–2064.

    Article  CAS  Google Scholar 

  25. Tralongo P, Dimari A, Conti G, Aiello R, Mauceri G . Central nervous system side-effects of 5-HT 3-receptor antagonists in elderly cancer patients treated with chemotherapy [1]. Ann Oncol. 2004; 15: 987–988.

    Article  CAS  Google Scholar 

  26. McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H et al. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989; 28: 233–244.

    Article  CAS  Google Scholar 

  27. Feliciano DP, Sahbaie P, Shi X, Klukinov M, Clark JD, Yeomans DC . Nociceptive sensitization and BDNF up-regulation in a rat model of traumatic brain injury. Neurosci Lett 2014; 583: 55–59.

    Article  CAS  Google Scholar 

  28. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA

    A C Meidahl, M Klukinov, A Z Tzabazis & D C Yeomans

  2. Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark

    A C Meidahl & J C Sorensen

Authors
  1. A C Meidahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Klukinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Z Tzabazis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J C Sorensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D C Yeomans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D C Yeomans.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meidahl, A., Klukinov, M., Tzabazis, A. et al. Nasal application of HSV encoding human preproenkephalin blocks craniofacial pain in a rat model of traumatic brain injury. Gene Ther 24, 482–486 (2017). https://doi.org/10.1038/gt.2017.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2017.55

This article is cited by

Search

Advanced search

Quick links